The Effects of a Mediterranean Diet Intervention on Cancer-Related Fatigue for Patients Undergoing Chemotherapy: A Pilot Randomized Controlled Trial
Authors:
- Amber S. KlecknerAKAmber S. Kleckner
- Jennifer E. ReschkeJRJennifer E. Reschke
- Ian R. KlecknerIKIan R. Kleckner
- Allison MagnusonAMAllison Magnuson
- Andrea M. AmitranoAAAndrea M. Amitrano
- Eva CulakovaECEva Culakova
- Michelle ShayneMSMichelle Shayne
- Colleen S. Netherby-WinslowCNColleen S. Netherby-Winslow
- Susan CzapSCSusan Czap
- Michelle C. JanelsinsMJMichelle C. Janelsins
- Karen M. MustianKMKaren M. Mustian
- Luke J. PepponeLPLuke J. Peppone
Open Access
Abstract
Cancer-related fatigue is a common, burdensome symptom of cancer and a side-effect of chemotherapy. While a Mediterranean Diet (MedDiet) promotes energy metabolism and overall health, its effects on cancer-related fatigue remain unknown. In a randomized controlled trial, we evaluated a rigorous MedDiet intervention for feasibility and safety as well as preliminary effects on cancer-related fatigue and metabolism compared to usual care. Participants had stage I–III cancer and at least six weeks of chemotherapy scheduled. After baseline assessments, randomization occurred 2:1, MedDiet:usual care. Measures were collected at baseline, week 4, and week 8 including MedDiet adherence (score 0–14), dietary intake, and blood-based metabolic measures. Mitochondrial respiration from freshly isolated T cells was measured at baseline and four weeks. Participants (n = 33) were 51.0 ± 14.6 years old, 94% were female, and 91% were being treated for breast cancer. The study was feasible, with 100% completing the study and >70% increasing their MedDiet adherence at four and eight weeks compared to baseline. Overall, the MedDiet intervention vs. usual care had a small-moderate effect on change in fatigue at weeks 4 and 8 (ES = 0.31, 0.25, respectively). For those with a baseline MedDiet score n = 21), the MedDiet intervention had a moderate-large effect of 0.67 and 0.48 at weeks 4 and 8, respectively. The MedDiet did not affect blood-based lipids, though it had a beneficial effect on fructosamine (ES = −0.55). Fatigue was associated with mitochondrial dysfunction including lower basal respiration, maximal respiration, and spare capacity (p < 0.05 for FACIT-F fatigue subscale and BFI, usual fatigue). In conclusion, the MedDiet was feasible and attenuated cancer-related fatigue among patients undergoing chemotherapy, especially those with lower MedDiet scores at baseline.Keywords
All Related Versions
Funding Information
- National Institutes of Health (NIH) National Cancer Institute (NCI) (UG1CA189961, T32CA102618, K07CA221931)
- Maryland Department of Health’s Cigarette Restitution Fund Program
This publication has 71 references indexed in Scilit:
- A 14-Item Mediterranean Diet Assessment Tool and Obesity Indexes among High-Risk Subjects: The PREDIMED TrialPLOS ONE, 2012
- Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention studyBreast Cancer Research and Treatment, 2012
- Potential Mechanisms by Which Polyphenol-Rich Grapes Prevent Obesity-Mediated Inflammation and Metabolic DiseasesAnnual Review of Nutrition, 2011
- Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytesThe Journal of Nutritional Biochemistry, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Design of a Mediterranean Exchange List Diet Implemented by Telephone CounselingJournal of the American Dietetic Association, 2008
- Considerations in determining sample size for pilot studiesResearch in Nursing & Health, 2008
- Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapyHead & Neck, 2005
- Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing RadiotherapyJournal of Clinical Oncology, 2005
- Fatigue in cancer patients during and after treatmentEuropean Journal of Cancer, 2002